Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.

Beck EJ, Avila C, Gerbase S, Harling G, De Lay P.

Pharmacoeconomics. 2012 Oct 1;30(10):887-902. doi: 10.2165/11596500-000000000-00000. Review.

PMID:
22830633
2.

Why and how to monitor the cost and evaluate the cost-effectiveness of HIV services in countries.

Beck EJ, Santas XM, Delay PR.

AIDS. 2008 Jul;22 Suppl 1:S75-85. doi: 10.1097/01.aids.0000327626.77597.fa.

PMID:
18664958
3.
5.
6.

Public and private donor financing for health in developing countries.

Howard LM.

Infect Dis Clin North Am. 1991 Jun;5(2):221-34. Review.

PMID:
1869807
7.

Resource needs for adolescent friendly health services: estimates for 74 low- and middle-income countries.

Deogan C, Ferguson J, Stenberg K.

PLoS One. 2012;7(12):e51420. doi: 10.1371/journal.pone.0051420. Epub 2012 Dec 27.

8.

Health economics in developing countries.

Abel-Smith B.

J Trop Med Hyg. 1989 Aug;92(4):229-41. Review.

PMID:
2503621
9.

The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Levy A, Johnston K, Annemans L, Tramarin A, Montaner J.

Pharmacoeconomics. 2010;28 Suppl 1:35-47. doi: 10.2165/11587430-000000000-00000. Review.

PMID:
21182342
10.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
11.

HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.

Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG.

BMC Health Serv Res. 2007 Jul 12;7:108.

12.

The cost of treatment and care for people living with HIV infection: implications of published studies, 1999-2008.

Beck EJ, Harling G, Gerbase S, DeLay P.

Curr Opin HIV AIDS. 2010 May;5(3):215-24. doi: 10.1097/COH.0b013e32833860e9. Review.

PMID:
20539077
13.

[The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].

Kerouedan D.

Bull Soc Pathol Exot. 2010 May;103(2):119-22. doi: 10.1007/s13149-010-0051-2. Epub 2010 Apr 7. French.

PMID:
20376595
14.

The fall and rise of cost sharing in Kenya: the impact of phased implementation.

Collins D, Quick JD, Musau SN, Kraushaar K, Hussein IM.

Health Policy Plan. 1996 Mar;11(1):52-63.

15.

Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.

Beck EJ, Fasawe O, Ongpin P, Ghys P, Avilla C, De Lay P.

Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):293-311. doi: 10.1586/erp.13.28. Review.

PMID:
23763528
16.

Budgeting based on need: a model to determine sub-national allocation of resources for health services in Indonesia.

Ensor T, Firdaus H, Dunlop D, Manu A, Mukti AG, Ayu Puspandari D, von Roenne F, Indradjaya S, Suseno U, Vaughan P.

Cost Eff Resour Alloc. 2012 Aug 29;10(1):11.

17.
18.

The potential of health sector non-governmental organizations: policy options.

Gilson L, Sen PD, Mohammed S, Mujinja P.

Health Policy Plan. 1994 Mar;9(1):14-24.

19.

HIV prevention cost-effectiveness: a systematic review.

Galárraga O, Colchero MA, Wamai RG, Bertozzi SM.

BMC Public Health. 2009 Nov 18;9 Suppl 1:S5. doi: 10.1186/1471-2458-9-S1-S5. Review.

20.

The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.

Sulzbach S, De S, Wang W.

Health Policy Plan. 2011 Jul;26 Suppl 1:i72-84. doi: 10.1093/heapol/czr031.

Items per page

Supplemental Content

Write to the Help Desk